Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antiangiogenic agents in early development at Boehringer Ingelheim

May 4, 2004

Lilly claims TGF-beta receptor kinase inhibitors for cancer and other disorders

May 4, 2004

Antineoplastic effects of pioglitazone on malignant tumor growth in rat glioma model

May 4, 2004

Interim results for Theralux in NHL

May 3, 2004

S-3304 reported to inhibit MMP activity in advanced cancer

May 3, 2004

Praecis and Schering AG enter Plenaxis commercialization agreement

April 30, 2004

European approval for Velcade in multiple myeloma

April 30, 2004

New positive opinion for Herceptin plus Taxotere in E.U.

April 29, 2004

EntreMed completes phase I trial with reformulated Panzem

April 29, 2004

Allergan to withdraw PEP-005 INDs, resubmission planned

April 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...